Streetbeat News

Earnings

EAST

Eastside Distilling reported its Q2 net sales at $2.661M.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:59 pm

EIGR

Eiger BioPharmaceuticals reported Q2 losses of $(0.47) per share, missing the analyst consensus estimate of $(0.41) by 14.63%. However, the company's quarterly sales of $4.64 million beat the estimate of $4.57 million by 1.60%. This represents a 13.49% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:59 pm

LUCD

Lucid Diagnostics (NASDAQ:LUCD) reported Q2 losses of $(0.27) per share, beating the analyst consensus estimate of $(0.32) by 15.62%. However, the company's quarterly sales of $159.00K missed the analyst consensus estimate of $620.00K by 74.35%.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:58 pm

LOV

Spark Networks reported Q2 sales of $41.20 million, a decrease of 14.23% from $48.03 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:58 pm

ELTP

Elite Pharmaceuticals (OTC:ELTP) reported a 17.03% increase in Q1 sales, up from $7.67 million to $8.98 million YoY.

Portfolio Pulse from mahesh@benzinga.com

August 14, 2023 | 8:57 pm

AZTR

Anitra (AMEX:AZTR) reported Q2 losses of $(2.36) per share, a 3.67% increase YoY. The company also reported $172.00K in sales, a 102.35% increase YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:57 pm

MRKR

Marker Therapeutics reported Q2 earnings of $0.29 per share, a 126.36% increase YoY. However, sales decreased by 3.52% to $762.66K compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:57 pm

GROV

Grove Collaborative Hldgs (NYSE:GROV) reported Q2 losses of $(0.32) per share, missing the analyst consensus estimate of $(0.31) by 3.23%. However, the company's losses have decreased by 93.96% compared to the same period last year. Quarterly sales were $66.11 million, beating the analyst consensus estimate of $63.44 million by 4.20%, but this is a 16.62% decrease from last year's sales.

Portfolio Pulse from sunil@benzinga.com

August 14, 2023 | 8:56 pm

GOEV

Canoo reported Q2 losses of $(0.14) per share, beating the analyst consensus estimate of $(0.19) by 26.32 percent. This represents a 79.41 percent increase over losses from the same period last year.

Portfolio Pulse from vinayak@benzinga.com

August 14, 2023 | 8:56 pm

AREC

American Res (NASDAQ:AREC) reported Q2 losses of $(0.09) per share, missing the analyst consensus estimate of $(0.04) by 125%. The company also reported quarterly sales of $1.98 million, missing the analyst consensus estimate of $18.30 million by 89.17%. This represents a significant decrease in both earnings and sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:56 pm